Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

In the HD15 trial of the German Hodgkin Study Group, the negative predictive value (NPV) of positron emission tomography (PET) using [(18)F]-fluorodeoxyglucose in advanced-stage Hodgkin lymphoma (HL) was evaluated. A total of 817 patients were enrolled and randomly assigned to receive BEACOPP-based...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Kobe, Carsten, Dietlein, Markus, Franklin, Jeremy, Markova, Jana, Lohri, Andreas, Amthauer, Holger, Klutmann, Susanne, Knapp, Wolfram H., Zijlstra, Josee M., Bockisch, Andreas, Weckesser, Matthias, Lorenz, Reinhard, Schreckenberger, Mathias, Bares, Roland, Eich, Hans T., Mueller, Rolf-Peter, Fuchs, Michael, Borchmann, Peter, Schicha, Harald, Diehl, Volker, Engert, Andreas
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2008
Pynciau:
Clinical Trials and Observations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2581984/
https://ncbi.nlm.nih.gov/pubmed/18757777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-06-155820
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg